ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,056Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 761

$927K Total Retail Price of All Prescriptions

Rank: 13 out of 761

767 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 767 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

22% of this provider’s 767 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 14,688 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 854 787 1 1
HYDROCODONE-ACETAMINOPHEN 807 536 S3 2 5
LEVOTHYROXINE SODIUM 587 500 3 3
AMLODIPINE BESYLATE 559 506 4 6
METOPROLOL TARTRATE 441 404 5 14
FUROSEMIDE 440 360 6 7
WARFARIN SODIUM 436 383 7 9
OMEPRAZOLE 436 323 7 4
PRAVASTATIN SODIUM 404 327 9 20
SIMVASTATIN 394 354 10 2
GABAPENTIN 392 253 11 15
OXYCODONE HCL 390 213 S2 12 24
TRAMADOL HCL 380 298 13 34
METFORMIN HCL 323 233 14 10
HYDROCHLOROTHIAZIDE 303 259 15 11
CITALOPRAM HBR 260 211 16 19
TRAZODONE HCL 250 185 17 23
ATORVASTATIN CALCIUM 223 185 18 12
DONEPEZIL HCL 206 206 19 33
MIRTAZAPINE 205 181 20 50
DIVALPROEX SODIUM 178 164 21 97
POTASSIUM CHLORIDE 175 150 22 18
ATENOLOL 175 164 22 8
CYMBALTA 172 92 24 53
BUPROPION HCL 172 140 24 227
SERTRALINE HCL 171 118 26 25
NAMENDA 167 167 27 59
GLIPIZIDE 165 123 28 39
CYCLOBENZAPRINE HCL 157 70 R 29 51
ALENDRONATE SODIUM 157 142 29 21
PROAIR HFA 154 114 31 32
METOPROLOL SUCCINATE 154 128 31 16
CARVEDILOL 149 136 33 26
FLUTICASONE PROPIONATE 149 115 33 29
ALLOPURINOL 140 129 35 28
FLUOXETINE HCL 130 96 36 31
ZOLPIDEM TARTRATE 122 70 37 22
FENTANYL 122 107 S2 37 57
LOSARTAN POTASSIUM 118 115 39 13
QUETIAPINE FUMARATE 108 82 40 90
METHADONE HCL 107 0 S2 41 75
MORPHINE SULFATE ER 107 56 S2 41 38
TRIAMCINOLONE ACETONIDE 106 82 43 84
RANITIDINE HCL 103 66 44 52
PREDNISONE 102 65 45 30
POLYETHYLENE GLYCOL 3350 100 83 46 62
LOVASTATIN 97 92 47 17
PAROXETINE HCL 95 57 48 47
DIOVAN 89 89 49 58
CRESTOR 86 72 50 36
ESTRADIOL 84 39 R 51 80
OXYCODONE-ACETAMINOPHEN 84 57 S2 51 49
LANTUS 83 57 53 41
DOXAZOSIN MESYLATE 83 82 53 55
TAMSULOSIN HCL 82 73 55 27
ESCITALOPRAM OXALATE 80 73 56 102
BUSPIRONE HCL 78 41 57 154
NEXIUM 77 47 58 98
PROMETHAZINE HCL 74 25 R 59 104
DIGOXIN 74 70 59 43
CIPROFLOXACIN HCL 72 63 61 63
BENICAR 69 69 62 81
CHLORTHALIDONE 69 67 62 89
CEPHALEXIN 69 52 62 145
GLIMEPIRIDE 64 62 65 48
SPIRIVA 63 40 66 56
ADVAIR DISKUS 63 45 66 37
ROPINIROLE HCL 62 23 68 95
OLANZAPINE 61 54 69 144
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 46 70 35
CLOPIDOGREL 56 50 71 66
AMITRIPTYLINE HCL 56 32 R 71 54
ENALAPRIL MALEATE 55 54 73 71
CLONIDINE HCL 55 50 73 69
LYRICA 54 27 75 134
NYSTOP 53 45 76 270
GEMFIBROZIL 52 33 77 116
TERAZOSIN HCL 52 52 77 86
KLOR-CON M10 51 49 79 197
PANTOPRAZOLE SODIUM 51 44 79 40
CARBIDOPA-LEVODOPA 50 29 81 82
FAMOTIDINE 50 37 81 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.